Skip to main content
. 2017 Sep 22;114(41):E8703–E8710. doi: 10.1073/pnas.1704661114

Table S2.

Gel filtration elution volume (Ve) for various gHgL/gp42 complexes with anti-gHgL Fab

Sample no. Glycoprotein complex Ve, mL Apparent molecular mass, kDa*
1 CL40 Fab/gHgL 11.61 179.4
2 CL59 Fab/gHgL 11.73 169.9
3 E1D1 Fab/gHgL 11.52 186.8
4 CL40 Fab/gHgL/gp42(47–81) 11.62 178.6
5 CL59 Fab/gHgL/gp42(47–81) 11.52 186.8
6 E1D1 Fab/gHgL/gp42(47–81) 11.39 198.1
7 CL40 Fab/gHgL/gp42 WT 11.23 212.9
8 CL59 Fab/gHgL/gp42 WT 11.05 230.9
9 E1D1 Fab/gHgL/gp42 WT 10.60 282.8
10 E1D1 Fab/CL40 Fab/gHgL/gp42(47–81) 10.80 258.4
11 CL59 Fab/E1D1 Fab/CL40 Fab/gHgL/gp42(47–81) 10.41 308.1
*

Apparent molecular mass was calculated using the following formula after S200 calibration: log10(molecular mass, kDa) = −0.1958 × (Ve, mL) + 4.527; R2 = 0.9912; column efficiency: N/m = 12,137 (acceptable, N/m >10,000); peak symmetry: As = 1.227 (acceptable, 0.70 < As < 1.30).

gp42(47–81) or gp42 35merA119 sequence: 47KPNVEVWPVDPPPPVNFNKTAEQEYGDKEVKLPHW81.